Low levels of hepatitis C diagnosis and testing uptake among
people who inject image and performance enhancing drugs in England and
Wales, 2012-15.
Hope VD, McVeigh J, Smith J, et al
Drug Alcohol Depend. 2017
Jul 18;179:83-86.
Abstract
Modelling the impact of incarceration and
prison-based hepatitis C virus (HCV) treatment on HCV transmission among
people who inject drugs in Scotland.
Stone J, Martin NK, Hickman M, et al
Addiction. 2017 Mar 3.
Abstract
Risk of HIV and hepatitis B and C over time
among men who inject image and performance enhancing drugs in England and
Wales: results from cross-sectional prevalence surveys, 1992-2013.
Hope VD, Harris R, McVeigh J,
et
al
J Acquir Immune Defic Syndr.
2015 Sep 8
Abstract
Expansion of HCV treatment access to people who have injected
drugs through effective translation of research into public health policy:
Scotland's experience.
Hutchinson SJ, Dillon JF, Fox R,
et al
Int J Drug Policy. 2015 Jun 6.
Abstract
FULL-TEXT ARTICLE
Assessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected
People Who Inject Drugs in the UK and the Relationship between Treatment
Uptake and Efficacy on Future Infections.
Bennett H, McEwan P, Sugrue D, et al
PLoS One. 2015 May 4;10(5):e0125846
Paper
FULL-TEXT ARTICLE
Findings from Integrated Behavioral and Biologic Survey among Males Who
Inject Drugs (MWID) - Vietnam, 2009-2010: Evidence of the Need for an
Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus.
Nadol P, O'connor S, Duong H, et al
PLoS One. 2015 Feb 18;10(2):e0118304.
Paper
Estimating the number of people with hepatitis C virus who
have ever injected drugs and have yet to be diagnosed: an evidence synthesis
approach for Scotland.
Prevost TC, Presanis AM, Taylor A,
et al
Addiction. 2015 Apr
14.
Abstract
Screening for Hepatitis C in injecting and ex-injecting drug
users in North East Essex.
Bishton E, Oluboyede F, Grylls E, Woods L, Thomas S.
Public Health. 2014 Nov;128(11):1036-8.
Abstract
HCV treatment rates and sustained viral response among people who inject
drugs in seven UK sites: real world results and modelling of treatment
impact.
Martin NK, Foster GR, Vilar J, et al
J Viral Hepat. 2014 Oct
7. d
Abstract
FULL-TEXT
PDF ARTICLE
Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with
National Scale-Up in Coverage of a Combination of Harm Reduction
Interventions.
Palmateer NE, Taylor A, Goldberg DJ, et al
PLoS One. 2014 Aug
11;9(8):e104515
Paper
Factors associated with recently acquired hepatitis C virus
infection in people who inject drugs in England, Wales and Northern Ireland: new
findings from an unlinked anonymous monitoring survey.
Cullen KJ, Hope VD, Croxford S,
et al
Epidemiol Infect. 2014 Aug 14:1-10.
Abstract
Risk of transmission associated with sharing drug injecting
paraphernalia: analysis of recent hepatitis C virus (HCV) infection using
cross-sectional survey data.
Palmateer N, Hutchinson S, McAllister G, et al
J Viral Hepat. 2014 Jan;21(1):25-32.
Abstract
FULL-TEXT ARTICLE
Cost-effectiveness of
HCV case-finding for people who inject drugs via dried blood spot testing in
specialist addiction services and prisons.
Martin NK, Hickman M, Miners A, et al
BMJ Open. 2013 Aug 13;3(8).
Paper
Estimating the number of injecting drug users in Scotland's
HCV-diagnosed population using capture-recapture methods.
McDonald SA, Hutchinson SJ, Schnier C, et al
Epidemiol Infect. 2013 Mar 22:1-8.
Abstract |